文献速递类风湿关节炎

患者报告结局作为类风湿关节炎停药后复发的早期预警信号

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.
PubMed 文献 · RMD Open · 2025-04-01

在BIO-FLARE前瞻性队列中,121例持续缓解并停用csDMARD的类风湿关节炎患者中58例(47.9%)发生复发;基线及随访时采集的四种患者报告结局(FLARE-RA、EQ5D、RAPID-3、RA-FQ)评分每变化1分均与复发风险显著相关(p<0.001),RA-FQ与FLARE-RA的ROC曲线下面积均为0.90(95%CI 0.84至0.96;p=0.001)。

要点

  • 停用csDMARD后6个月内47.9%(58/121)患者复发。
  • 四种PRO评分每变化1分均与复发风险显著相关(p<0.001)。
  • RA-FQ较基线升高≥5.5分识别客观复发的阳性预测值80%、阴性预测值91%。

核心结论

  • 数据支持对无药缓解的类风湿关节炎患者进行远程PRO监测以识别复发发生的潜在价值。

研究设计与样本

  • BIO-FLARE前瞻性队列研究,纳入持续缓解后停用csDMARD的类风湿关节炎患者121例,在基线和序贯访视至复发或6个月随访结束时采集四种PRO。

主要发现

  • 58/121(47.9%)参与者发生复发,其中女性占70.1%,平均年龄64.8岁。
  • 多变量Cox回归模型中每种PRO评分每变化1分均与复发发生强烈相关(每种情况p<0.001)。
  • ROC曲线分析证实监测PRO较基线的恶化变化对识别复发具有稳健的判别效用,以RA-FQ和FLARE-RA最为明显(曲线下面积均为0.90,95%CI 0.84至0.96;p=0.001)。
  • RA-FQ较基线升高≥5.5分识别客观复发的阳性预测值为80%、阴性预测值为91%。

关键数值与推荐

  • 复发定义为以下任一:任一次访视DAS28-CRP≥3.2;2周内两次访视DAS28-CRP≥2.4;尽管DAS28-CRP<2.4仍恢复DMARD和/或激素治疗。

临床怎么用

  • 原文结论为数据支持远程PRO监测对无药缓解类风湿关节炎患者识别复发发生的潜在价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Drug withdrawal in rheumatoid arthritis (RA) in remission can reduce toxicity, but with the risk of flare which requires close monitoring. We explored the potential of patient-reported outcomes (PROs) for flare detection among RA patients in sustained remission after conventional synthetic disease-modifying antirheumatic drug (csDMARD) cessation. METHODS: Four PROs (Factors that Limit sustAined Remission in rhEumatoid arthritis (FLARE-RA), EuroQol-5 Dimensions (EQ5D), Routine Assessment of Patient Index Data-3 (RAPID-3) and RA Flare Questionnaire (RA-FQ)) were captured at baseline and at sequential visits until time-of-flare or end of 6-month follow-up as part of the BIO-FLARE prospective cohort study. Flare was defined as any of (i) Disease Activity Score 28 (DAS28)-C reactive protein (CRP) ≥3.2 at any visit, (ii) DAS28-CRP≥2.4 on two visits within 2 weeks or (iii) resuming DMARD and/or steroid therapy despite DAS28-CRP<2.4. Cox regression models with time-varying covariates were fitted to evaluate associations between PRO changes and likelihood of flare. Receiver-operating characteristic (ROC) curves enabled discriminatory changes in each PRO to be compared as a means of identifying flare. RESULTS: 58/121 (47.9%) participants (70.1% females, mean age 64.8 years) experienced a flare. A 1-point change in each PRO score was strongly associated with flare development in the multivariate Cox regression model (p<0.001 in each case). ROC curve analysis confirmed that monitoring adverse changes in PROs from baseline offered robust discriminatory utility for identifying flare occurrence. This was most evident for RA-FQ and FLARE-RA (both areas under the curves 0.90, 95% CI 0.84 to 0.96; p=0.001); for example, an RA-FQ increment of ≥5.5 from baseline identified objective flare with positive and negative predictive values of 80% and 91%, respectively. CONCLUSIONS: Our data support the potential value of remote PRO monitoring of RA patients in drug-free remission to identify flare occurrence.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Gumber L, Rayner F, Bigirumurame T, et al. Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis. RMD Open. 2025. PMID: 40169281. doi:10.1136/rmdopen-2025-005442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。